The emergence of off-brand imatinib represents a substantial opportunity for patients battling chronic myeloid leukemia and other diseases. Original brand-name imatinib, branded as Gleevec, carries a high price cost, https://careprost190751.rider-blog.com/811146/generic-gleevec-a-cost-effective-alternative